{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:12:22Z","timestamp":1772003542149,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.brainresbull.2008.08.023","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T04:42:16Z","timestamp":1222317736000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of behavioural effects of a selective NMDA NR1A\/2B receptor antagonist in the unilateral 6-OHDA lesion rat model"],"prefix":"10.1016","volume":"78","author":[{"given":"S.T.","family":"Warraich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.N.","family":"Allbutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Billing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Radford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Coster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kassiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2008.08.023_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainresbull.2008.08.023_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0024-3205(87)90576-5","article-title":"Spontaneous asymmetric curling behavior in hemiparkinsonism; a human equivalent of the lesioned-circling rodent behavior","volume":"40","author":"Bracha","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib3","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","article-title":"Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias","volume":"127","author":"Calon","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.brainresbull.2008.08.023_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.10343","article-title":"Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications","volume":"18","author":"Calon","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","article-title":"Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease","volume":"14","author":"Calon","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1109\/TNSRE.2007.908933","article-title":"Locomotor function in the early stage of Parkinson's disease","volume":"15","author":"Carpinella","year":"2007","journal-title":"IEEE Trans. Neural Syst. Rehabil. Eng."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0960-894X(02)01061-2","article-title":"Orally efficacious NR2B-selective NMDA receptor antagonists","volume":"13","author":"Claiborne","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-d-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00002826-199402000-00013","article-title":"Apomorphine and diphasic dyskinesia","volume":"17","author":"Durif","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib10","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1523\/JNEUROSCI.5326-05.2006","article-title":"A critical interaction between NR2B and MAGUK in L-dopa induced dyskinesia","volume":"26","author":"Gardoni","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson's disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib12","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1046\/j.1460-9568.1999.00692.x","article-title":"Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat","volume":"11","author":"Henderson","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2005.03.017","article-title":"Behavioural effects of parafascicular thalamic lesions in an animal model of parkinsonism","volume":"162","author":"Henderson","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(02)00087-6","article-title":"Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat","volume":"139","author":"Henderson","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0361-9230(03)00032-7","article-title":"Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naive and 6-hydroxydopamine lesioned rats","volume":"60","author":"Henderson","year":"2003","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(98)00431-5","article-title":"Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus\/substantia nigra pars reticulata than in the subthalamic nucleus","volume":"249","author":"Honey","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib17","first-page":"13","article-title":"Brain monoamines and parkinsonism","volume":"3","author":"Hornykiewicz","year":"1975","journal-title":"Natl. Inst. Drug Abuse Res. Monogr. Ser."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0091-3057(94)90469-3","article-title":"Conditioned apomorphine-induced turning in 6-OHDA-lesioned rats","volume":"49","author":"Hudson","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(01)03147-X","article-title":"MK801 supresses the L-dopa-induced increase of glutamate in striatum of hemi-Parkinson rats","volume":"926","author":"Jonkers","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-2-8","article-title":"An MCASE approach to the search of a cure for Parkinson's Disease","volume":"2","author":"Klopman","year":"2002","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0090-3019(01)00578-X","article-title":"Neurosurgical intervention for Parkinson's disease: an update","volume":"56","author":"Kolchinsky","year":"2001","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(02)00302-9","article-title":"The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications","volume":"97","author":"Loftis","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jns.2004.02.022","article-title":"Clinical gait and balance scales for Parkinson's disease","volume":"221","author":"Martinez-Martin","year":"2004","journal-title":"J. Neurol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.brainresbull.2008.08.023_bib24","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/s100720300035","article-title":"Autonomic dysfunction in Parkinson's disease","volume":"24","author":"Micieli","year":"2003","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0149-7634(96)00035-8","article-title":"Glutamate antagonists and Parkinson's disease: a review of clinical data","volume":"21","author":"Montastruc","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/syn.20295","article-title":"Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adensoine A2A receptors","volume":"60","author":"Morrisette","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.brainresbull.2008.08.023_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mds.10107","article-title":"Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat","volume":"17","author":"Nash","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.expneurol.2004.05.004","article-title":"The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"188","author":"Nash","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/23.1.234988","article-title":"Cellular localization of tyrosine hydroxylase by immunohistochemistry","volume":"23","author":"Pickel","year":"1975","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0006-8993(01)02086-8","article-title":"NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats","volume":"897","author":"Pollack","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0166-4328(88)90003-4","article-title":"\u2018Disengage\u2019 sensorimotor deficit following apparent recovery from unilateral dopamine depletion","volume":"30","author":"Schallert","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainresbull.2008.08.023_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00726-001-0120-8","article-title":"Glutamatergic mechanisms in different disease states: overview and therapeutical implications\u2014an introduction","volume":"23","author":"Tzschentke","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.brainresbull.2008.08.023_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res."}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192300800302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036192300800302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:05:01Z","timestamp":1759781101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036192300800302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":34,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S036192300800302X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2008.08.023","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of behavioural effects of a selective NMDA NR1A\/2B receptor antagonist in the unilateral 6-OHDA lesion rat model","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2008.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}